U.S. Files Patent For LUCIFERASE

 


The book of Revelation is happening before our very own eyes…

The United States Government has patented a new product that uses luciferase and bioluminescent material.

Look closely at the word LUCIFERase, as most of you know Lucifer is another name for the devil.

The patent was filed by the Department of Homeland Security and the luciferase/bioluminescent product will be a way to “mark” people as a way to verify if they had vaccinations or not.

Here’s the abstract from the official patent:

Polynucleotides encoding fusion proteins contain a secretable luciferase fused to a modified polypeptide of interest are disclosed. The polypeptide of interest has been modified to remove a native N-terminal secretion sequence and has been replaced by the secretable luciferase. One example of a modified polypeptide of interest is interferon.

The polynucleotides and fusion proteins have biotherapeutic, diagnostic, and quality control applications in biotechnological, medical, and veterinary fields. Methods for producing the secretable fusion protein are also disclosed.

Previously Bill Gates was working on a project with MIT, which aimed to create invisible ink that acted as a tattoo that would contain medical data.

The Scientific American had more on Gate’s project:

Keeping track of vaccinations remains a major challenge in the developing world, and even in many developed countries, paperwork gets lost, and parents forget whether their child is up to date. Now a group of Massachusetts Institute of Technology researchers has developed a novel way to address this problem: embedding the record directly into the skin.

Along with the vaccine, a child would be injected with a bit of dye that is invisible to the naked eye but easily seen with a special cell-phone filter, combined with an app that shines near-infrared light onto the skin. The dye would be expected to last up to five years, according to tests on pig and rat skin and human skin in a dish.

The system—which has not yet been tested in children—would provide quick and easy access to vaccination history, avoid the risk of clerical errors, and add little to the cost or risk of the procedure, according to the study, published Wednesday in Science Translational Medicine.

Previous Post Next Post